Entity Common Stock, Shares Outstanding of BIOMARIN PHARMACEUTICAL INC from 23 Jul 2010 to 23 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BIOMARIN PHARMACEUTICAL INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 23 Jul 2010 to 23 Oct 2025.
  • BIOMARIN PHARMACEUTICAL INC Entity Common Stock, Shares Outstanding for the quarter ending 23 Oct 2025 was 192,114,344, a 0.8% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 192,114,344 +1,531,328 +0.8% 23 Oct 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 192,014,601 +1,631,779 +0.86% 28 Jul 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 191,775,665 +1,895,862 +1% 25 Apr 2025 10-Q 02 May 2025 2025 Q1
Q3 2024 190,583,016 +2,214,845 +1.2% 28 Oct 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 190,382,822 +2,208,049 +1.2% 31 Jul 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 189,879,803 +2,178,861 +1.2% 22 Apr 2024 10-Q 26 Apr 2024 2024 Q1
Q3 2023 188,368,171 +2,519,256 +1.4% 30 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 188,174,773 +2,700,906 +1.5% 28 Jul 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 187,700,942 +2,705,594 +1.5% 25 Apr 2023 10-Q 28 Apr 2023 2023 Q1
Q3 2022 185,848,915 +2,255,481 +1.2% 25 Oct 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 185,473,867 +2,121,612 +1.2% 28 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 184,995,348 +2,252,775 +1.2% 25 Apr 2022 10-Q 29 Apr 2022 2022 Q1
Q3 2021 183,593,434 +2,063,767 +1.1% 26 Oct 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 183,352,255 +2,002,658 +1.1% 27 Jul 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 182,742,573 +1,905,717 +1.1% 21 Apr 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 181,829,680 +1,904,078 +1.1% 12 Feb 2021 10-K 26 Feb 2021 2020 FY
Q3 2020 181,529,667 +1,904,364 +1.1% 23 Oct 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 181,349,597 +1,886,838 +1.1% 30 Jul 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 180,836,856 +1,765,503 +0.99% 20 Apr 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 179,925,602 +1,553,400 +0.87% 12 Feb 2020 10-K 27 Feb 2020 2019 FY
Q3 2019 179,625,303 +1,563,197 +0.88% 18 Oct 2019 10-Q/A 04 Nov 2019 2019 Q3
Q2 2019 179,462,759 +1,872,383 +1.1% 22 Jul 2019 10-Q 02 Aug 2019 2019 Q2
Q1 2019 179,071,353 +2,358,039 +1.3% 15 Apr 2019 10-Q 29 Apr 2019 2019 Q1
Q4 2018 178,372,202 +2,299,941 +1.3% 12 Feb 2019 10-K 28 Feb 2019 2018 FY
Q3 2018 178,062,106 +2,440,829 +1.4% 19 Oct 2018 10-Q 26 Oct 2018 2018 Q3
Q2 2018 177,590,376 +2,322,055 +1.3% 23 Jul 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 176,713,314 +2,223,289 +1.3% 13 Apr 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 176,072,261 +3,205,766 +1.9% 13 Feb 2018 10-K 26 Feb 2018 2017 FY
Q3 2017 175,621,277 +3,633,840 +2.1% 25 Oct 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 175,268,321 +11,802,500 +7.2% 20 Jul 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 174,490,025 +12,167,586 +7.5% 20 Apr 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 172,866,495 +11,275,815 +7% 13 Feb 2017 10-K 27 Feb 2017 2016 FY
Q3 2016 171,987,437 +10,735,722 +6.7% 28 Oct 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 163,465,821 +2,371,711 +1.5% 29 Jul 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 162,322,439 +1,985,677 +1.2% 22 Apr 2016 10-Q 02 May 2016 2016 Q1
Q4 2015 161,590,680 +2,454,983 +1.5% 12 Feb 2016 10-K 29 Feb 2016 2015 FY
Q3 2015 161,251,715 +13,786,169 +9.3% 23 Oct 2015 10-Q 02 Nov 2015 2015 Q3
Q2 2015 161,094,110 +13,977,237 +9.5% 27 Jul 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 160,336,762 +14,409,964 +9.9% 24 Apr 2015 10-Q 05 May 2015 2015 Q1
Q4 2014 159,135,697 +15,512,473 +11% 13 Feb 2015 10-K 02 Mar 2015 2014 FY
Q3 2014 147,465,546 +5,252,889 +3.7% 18 Oct 2014 10-Q 28 Oct 2014 2014 Q3
Q2 2014 147,116,873 +7,011,282 +5% 18 Jul 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 145,926,798 +6,916,623 +5% 18 Apr 2014 10-Q 02 May 2014 2014 Q1
Q4 2013 143,623,224 14 Feb 2014 10-K 26 Feb 2014 2013 FY
Q3 2013 142,212,657 +18,386,591 +15% 18 Oct 2013 10-Q 28 Oct 2013 2013 Q3
Q2 2013 140,105,591 +16,550,347 +13% 19 Jul 2013 10-Q 29 Jul 2013 2013 Q2
Q1 2013 139,010,175 +23,309,192 +20% 19 Apr 2013 10-Q 29 Apr 2013 2013 Q1
Q3 2012 123,826,066 +9,611,659 +8.4% 12 Oct 2012 10-Q 29 Oct 2012 2012 Q3
Q2 2012 123,555,244 +11,727,954 +10% 13 Jul 2012 10-Q 02 Aug 2012 2012 Q2
Q1 2012 115,700,983 +4,791,392 +4.3% 13 Apr 2012 10-Q 30 Apr 2012 2012 Q1
Q4 2011 115,056,998 13 Feb 2012 10-K 22 Feb 2012 2011 FY
Q3 2011 114,214,407 +11,717,282 +11% 15 Oct 2011 10-Q 31 Oct 2011 2011 Q3
Q2 2011 111,827,290 +9,768,630 +9.6% 15 Jul 2011 10-Q 01 Aug 2011 2011 Q2
Q1 2011 110,909,591 15 Apr 2011 10-Q 29 Apr 2011 2011 Q1
Q3 2010 102,497,125 22 Oct 2010 10-Q 29 Oct 2010 2010 Q3
Q2 2010 102,058,660 23 Jul 2010 10-Q 04 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.